Image

Cardiovascular Magnetic Resonance in Adults With SysTemic Right Ventricle (STAR)

Recruiting
18 years of age
Both
Phase N/A

Powered by AI

Overview

The main aim of the study is to explore HFs in SRV, comparing their magnitude and direction with that of subpulmonary RV and systemic LV. As a secondary aim, possible association or correlation will be investigated between SRV energetics and: i) patient functional parameters, e.g., the results from cardiopulmonary exercise test (CPET), ii) patient clinical status, including the occurrence of adverse outcome (a composite of death, hospitalization for heart failure, cardiovascular arrest, sustained arrhythmias).

Eligibility

Inclusion Criteria:Case group:

The study will include patients aged ≥ 18 years with the diagnosis of L-TGA and D-TGA, who:

  • are admitted to UNICCA, the Adult Congenital Heart Unit or
  • are scheduled for a Cardiovascular Magnetic Resonance examination in this Institution

Control group:

        The study will include subjects aged ≥ 18 years who will invited for a Cardiovascular
        Magnetic Resonance examination in our Institution. This group of control will include n=15
        of adult healthy subjects. A further inclusion criteria for the control subjects are age
        and male proportion comparable to those of the TGA group.
        Exclusion Criteria:
          -  (case and control group)
               -  Subjects with intrabody ferromagnetic material precluding subject's safety
               -  Subjects with non CMR-conditional devices
               -  Subjects with claustrophobia or breath-holding precluding an adequate CMR and 4D
                  Flow images quality
               -  Pregnant women

Study details

Transposition of Great Arteries

NCT05690854

IRCCS Policlinico S. Donato

25 January 2024

Step 1 Get in touch with the nearest study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer  to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.